T1	chemical 0 12	Temozolomide
T2	chemical 22 26	drug
T3	disease_or_phenotypic_feature 63 72	malignant
T4	chemical 135 142	protein
T5	chemical 143 152	biomarker
T6	disease_or_phenotypic_feature 157 170	schizophrenia
T7	disease_or_phenotypic_feature 356 372	bipolar disorder
T8	chemical 387 394	alcohol
T9	disease_or_phenotypic_feature 488 503	cervical cancer
T10	chemical 561 572	doxorubicin
T11	chemical 632 641	drug-free
T12	chemical 694 703	rapamycin
T13	chemical 712 727	mTOR inhibitors
T14	disease_or_phenotypic_feature 784 791	hepatic
T15	disease_or_phenotypic_feature 849 856	obesity
T16	chemical 858 867	Metformin
T17	disease_or_phenotypic_feature 877 889	hypoglycemic
T18	chemical 929 937	hormonal
T19	chemical 1017 1028	chlorophyll
T20	chemical 1036 1047	carotenoids
T21	chemical 1052 1064	xanthophylls
T22	disease_or_phenotypic_feature 1088 1104	mite infestation
T23	chemical 1308 1323	steroid-induced
T24	disease_or_phenotypic_feature 1324 1332	glaucoma
T25	disease_or_phenotypic_feature 1361 1388	vernal keratoconjunctivitis
T26	chemical 1437 1451	growth hormone
T27	disease_or_phenotypic_feature 1465 1472	obesity
T28	chemical 1485 1499	chlorpromazine
T29	chemical 1510 1517	antigen
T30	disease_or_phenotypic_feature 1577 1592	pulmonary edema
T31	chemical 1619 1633	pegcantratinib
T32	disease_or_phenotypic_feature 1637 1647	skin tumor
T33	chemical 1701 1705	drug
T35	chemical 1764 1772	antigens
T36	disease_or_phenotypic_feature 1814 1820	cancer
T37	disease_or_phenotypic_feature 2000 2009	infection
T38	chemical 2044 2059	polysaccharides
T39	disease_or_phenotypic_feature 2191 2196	blood
T40	disease_or_phenotypic_feature 2229 2234	blood
T41	chemical 2291 2296	lipid
T42	disease_or_phenotypic_feature 2361 2376	prostate cancer
T43	chemical 2418 2424	oxygen
T44	chemical 2457 2465	estrogen
T45	chemical 2470 2482	progesterone
T46	disease_or_phenotypic_feature 2582 2595	breast cancer
T47	chemical 2639 2654	phosphorylation
T48	chemical 2707 2722	phosphorylation
T49	chemical 2912 2926	phosphorylated
T50	chemical 2927 2935	residues
T51	disease_or_phenotypic_feature 2960 2964	rich
T52	chemical 2975 2983	residues
T53	disease_or_phenotypic_feature 3092 3118	small bowel adenocarcinoma
T54	chemical 3213 3232	glucose-transporter
T55	disease_or_phenotypic_feature 3303 3306	ICC
T56	chemical 3458 3461	DDD
T57	chemical 3522 3525	PDX
T58	disease_or_phenotypic_feature 3562 3568	cancer
T59	chemical 3569 3576	biology
T60	corrected_disease_or_phenotypic_feature 63 80	malignant gliomas
R1	treats Arg1:T1 Arg2:T60	
T61	missed_chemical 118 129	Kininogen-1
T62	corrected_chemical 694 727	rapamycin-derived mTOR inhibitors
T63	corrected_disease_or_phenotypic_feature 784 798	hepatic tumour
R3	causes_or_contributes_to Arg1:T16 Arg2:T17	
T64	missed_chemical 1425 1432	insulin
T65	corrected_chemical 1747 1772	tumor-associated antigens
T66	missed_chemical 1774 1777	TAA
T67	missed_chemical 2028 2031	LPS
T68	missed_chemical 2451 2455	HER2
T69	missed_chemical 2677 2682	PfHP1
T70	missed_chemical 2701 2706	PfHP1
T71	missed_chemical 2809 2814	PfHP1
T72	missed_chemical 3026 3041	casein kinase 2
T73	missed_chemical 3043 3048	PfCK2
T74	missed_chemical 3241 3247	GLUT-1
T75	DONE 3578 3582	DONE
R6	treats Arg1:T10 Arg2:T9	
T76	corrected_chemical 1308 1315	steroid
R7	causes_or_contributes_to Arg1:T76 Arg2:T24	
R8	treats Arg1:T28 Arg2:T30	
R9	treats Arg1:T31 Arg2:T32	
R10	treats Arg1:T76 Arg2:T25	
T34	missed_disease_or_phenotypic_feature 1390 1393	VKC
R11	treats Arg1:T76 Arg2:T34	
R4	treats Arg1:T2 Arg2:T60	
T77	missed_disease_or_phenotypic_feature 110 116	tumors
R5	treats Arg1:T2 Arg2:T77	
R12	treats Arg1:T1 Arg2:T77	
T78	missed_disease_or_phenotypic_feature 915 945	metabolic and hormonal effects
R13	causes_or_contributes_to Arg1:T16 Arg2:T78	
R14	treats Arg1:T33 Arg2:T32	
